UNSPSC 51162416: Guaifenesin/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE516. This VA Drug Class (RE516) classifies this compound as belonging to the group DECONGESTANT/EXPECTORANT.

UNSPSC 51162416 Guaifenesin/phenylephrine/phenylpropanolamine is a Commodity code whose nominal scope does not match the state and local opportunities recently tagged under it. The two recent solicitations in the block procure naloxone and drug deactivation systems (Seminole County, Florida) and generic multi-source pharmaceuticals and over-the-counter products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). Neither opportunity targets the specific decongestant and expectorant combination named in the code. The mismatch signals either tagging inconsistency in state and local procurement systems or a categorical error in how the code is applied to these opportunities. Absent recent solicitations that actually seek guaifenesin/phenylephrine/phenylpropanolamine products specifically, this code shows little relevant recent activity for business development purposes.

The geographic spread and issuing-body mix reflect the posted opportunities rather than the code's nominal scope. Seminole County, Florida issued an IFB (Solicitation Number IFB60459723LAS) in June 2026 with a response deadline of July 26, 2023—a date inconsistency that suggests data quality issues in the source record. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP (Solicitation Number S1070000015802) posted January 20, 2026, with a response deadline of March 26, 2026, covering participating state and local government facilities across Minnesota and Oregon. The wide variance between the opportunities' actual scope and the code's pharmaceutical specificity indicates that this code may not be the appropriate tracking mechanism for meaningful analysis of state and local procurement in decongestant-expectorant combinations.